Sign in
YS Stock Price, Chart, Stats & News
YS Biopharma Co., Ltd.
Save
192.09M
Market cap
–
Current P/E
–
Forward P/E
YS chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 82.47% |
Operating margin | -14.03% |
Pretax margin | -16.41% |
Net margin | -16.26% |
Effective tax rate | 0.94% |
ROA | -7.31% |
ROE | -18.43% |
D/E | 0.83x |
Interest coverage ratio | -5.48x |
YS valuation
P/E | – |
P/S | 2.16x |
P/B | 1.51x |
P/CF | -6.23x |
P/FCF | -9.56x |
P/OCF | -6.23x |
PEG | -0.01x |
EV multiple | -19.39x |
About
YS Biopharma Co., Ltd., a biopharmaceutical firm established in Beijing, China, in 2002, specializes in the discovery, development, production, and commercialization of vaccines and therapeutic biologics. Their primary focus is on addressing infectious diseases and cancer. Central to their efforts is a proprietary PIKA immunomodulating technology platform, which supports the creation of preventive and therapeutic biologics for conditions such as Rabies, Coronavirus, Hepatitis B, Influenza, and Shingles.
Similar securities
Based on sector and market capitalization
Report issue